Hifuture Technology(SZ:002168) Zheng Quan Zhi Xing·2025-08-29 18:21Core Viewpoint - Chongqing Hifuture Information Technology Co., Ltd. reported a significant increase in revenue and a reduction in net loss for the first half of 2025, driven by the expansion of its pharmaceutical segment and improvements in operational efficiency [2][3]. Financial Performance - The company's operating revenue for the reporting period reached approximately 179.79 million yuan, a 61.54% increase compared to 111.30 million yuan in the same period last year [2][6]. - The net profit attributable to shareholders was a loss of approximately 31.67 million yuan, which is a 54.36% improvement from a loss of 69.39 million yuan in the previous year [2][3]. - The net cash flow from operating activities was approximately 51.19 million yuan, a significant turnaround from a negative cash flow of 50.50 million yuan in the previous year, marking a 201.36% increase [2][3]. Business Segments - The company operates in four main business segments: power distribution equipment, electric vehicle charging stations, photovoltaic and wind power EPC projects, and biopharmaceuticals [3][5]. - The pharmaceutical segment contributed significantly to revenue, generating approximately 103.23 million yuan, accounting for 57.41% of total revenue, which was a new addition to the company's portfolio [6]. - The electric vehicle charging station segment, through its subsidiary, provided integrated solutions for charging systems, with products designed for efficiency and safety [3][5]. Cost Management - The company's operating costs decreased by 8.46% to approximately 87.70 million yuan, reflecting effective cost control measures [5][6]. - Sales expenses surged by 436.73% to approximately 56.10 million yuan, primarily due to the expansion of the pharmaceutical business [5][6]. - Management expenses decreased by 48.20% to approximately 26.69 million yuan, indicating improved operational efficiency [5][6]. Asset and Liability Analysis - Total assets increased by 20.33% to approximately 952.07 million yuan compared to the previous year [2][8]. - The company's net assets attributable to shareholders were negative at approximately -95.79 million yuan, a decline of 74.72% from the previous year [2][8]. - The company reported an increase in accounts receivable, which reached approximately 245.67 million yuan, accounting for 25.80% of total assets [8][9]. Strategic Advantages - The company has established a strong brand presence in the power distribution equipment sector, leveraging over 20 years of industry experience [3][5]. - Continuous investment in research and development, particularly in the pharmaceutical sector, has enhanced the company's innovation capabilities [5][6]. - The strategic collaboration with local government resources is expected to create synergies that will support the company's growth trajectory [5][6].